Chemical Recycle of Plastics

whitePaper | January 16, 2022

This paper is published under the responsibility of the Secretary-General of the OECD. The opinions expressed and the arguments employed herein do not necessarily reflect the official views of OECD member countries.

whitePaper | December 13, 2019

The chemical industry has enjoyed strong and consistent performance over the last decade. The market is now being affected by new challenges, from increased global competition and changing customer requirements to disruptive new technologies while increased demand for sustainability, safety, and efficiency is changing not only the way companies work, but the products they produce.

whitePaper | August 24, 2022

Minnesota Department of Health (MDH) provided an update on the CEC Initiative program current and planned activities and projects at the annual CEC Initiative Partners meeting held August 24, 2022.

whitePaper | February 24, 2023

Solvents — specially formulated liquids that extract carbon dioxide from a mixture of other gases — have been used for decades, and are the most proven and mature carbon capture technologies on the market. They have been used in the petrochemical and fertiliser sectors for many years. Conventional solvents for carbon capture are amine-based, with the most common being monoethanolamine (MEA).

whitePaper | April 30, 2021

The manufacturing sector plays a significant role in the outputof the Indian economy, and chemical manufacturing is a crucialsegment with roots spread across a wide range of end-useindustries. With the index of industrial production (IIP) forchemical manufacturing returning to pre-COVID levels, theindustry is expected to grow at a CAGR of about 9.2% by FY25.7 Demographic dividends, low per capita consumption, an increasingexport demand and enabling Government initiatives are thekey growth drivers for the Indian chemical industry. Attractivebusiness opportunities are present in different segments, includingpetrochemical intermediates, downstream petrochemicals and specialty chemicals. The coming decade is expected to bring ininvestments worth more than USD 87 billion (solely on the basis ofthe major petrochemical products under consideration).

whitePaper | May 19, 2022

RAS (KRAS, HRAS, and NRAS) is the most frequently mutated gene family in human cancers that have been considered “undruggable” due to the elusive nature of RAS inhibitors.